Clinicoserological features of 11 systemic sclerosis (SSc) patients
| % | |
|---|---|
| Female–male | 10–1 |
| Age, mean (SD) (range) (y) | 40.5 (10.4) (21–57) |
| SSc duration, mean (SD) (range) (y) | 6.5 (5.8) (1–18) |
| SSc subsets | |
| Limited | 36 |
| Intermediate | 18 |
| Diffuse | 46 |
| Raynauld’s phenomenon | 100 |
| Telangectasias | 100 |
| Skin digital pitting | 72 |
| Cutaneous ulcers | 18 |
| Calcinosis | 18 |
| Oesophageal dysmotility | 72 |
| Lung fibrosis | 91 |
| Pulmonary hypertension | 27 |
| Heart involvement | 55 |
| Autoantibodies1-150 | |
| Anti-nuclear | 82 |
| Anti-ENA | 46 |
| Anti-centromere | 9 |
| Anti-Scl70 | 72 |
↵1-150 Anti-ENA: anti-extractable nuclear antigen; anti-Scl70: anti-topoisomerase I antibody.